Publications

Le 07 Déc 2020

Publications

Filtrer nos publications par :

Année

2016

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

To determine whether the ratio single chain (sc)/(sc + 2 chain [tc]) recombinant tissue plasminogen activator (rtPA) influences outcomes in (…)

Consulter

2017

Subarachnoid Hemorrhage Severely Impairs Brain Parenchymal Cerebrospinal Fluid Circulation in Nonhuman Primate.

Subarachnoid hemorrhage (SAH) is a devastating form of stroke with neurological outcomes dependent on the occurrence of delayed cerebral ischemia. (…)

Consulter

2018

Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.

Intracerebral hemorrhage (ICH) is the most severe form of stroke. Catheter-delivered thrombolysis with recombinant tissue-type plasminogen activator (rtPA) for the (…)

Consulter

2018

Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors.

Based on preclinical studies suggesting that recombinant tissue plasminogen activator (rt-PA) may promote ischemic brain injuries, we investigated in patients (…)

Consulter

2018

Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System.

Endothelial cells of the central nervous system over-express surface proteins during neurological disorders, either as a cause, or a consequence, (…)

Consulter

2018

Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.

Many patients who receive intravenous (i.v.) recombinant tissue-plasminogen activator (rt-PA) for acute cerebral ischemia were under angiotensin-converting enzyme inhibitors (ACE-Is) (…)